Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the AcucyTM Influenza A&B Test

October 7th, 2019|Tags: , , |

Burlington, MA – October 8, 2019 –Sekisui Diagnostics announces the Acucy Influenza A&B Test has received 510(k) clearance as a Class II assay from the US Food and Drug [...]


April 28th, 2017|

The SEKISUI OPEN will take place in the Sportpark Pilatus in Kriens, Switzerland from 16 to 21 May 2017. For the second time a PSA 5 women’s tournament will [...]

World Thrombosis Day – October 13

October 7th, 2015|

Think Venous Thromboembolism (VTE) 10 million cases of VTE are reported in Europe and US alone, leading to 1,600 deaths daily 1 in 4 people die from complications related to thrombosis, making it [...]

World Thrombosis Day

October 13th, 2014|

STOP BLOOD CLOTS, SAVE LIVES Thrombosis is the one disorder that causes the world's top three  cardiovascular killers. Heart attack, stroke, and venous thromboembolism (VTE) are the 3 leading [...]

New Sekisui Diagnostics Website Launches!

May 1st, 2014|

We are excited to announce the launch of the new Sekisui Diagnostics website. The site establishes a global, online presence highlighting our history, capabilities and brands while uniting Sekisui [...]

Site Search

Search Products

Search Documents